Is the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) score available in Singapore?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HOMA-IR Score Availability in Singapore

Yes, HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) is available in Singapore as it is a calculated index rather than a specific test or device requiring regulatory approval.

What HOMA-IR Is and How It Works

HOMA-IR is a mathematical calculation derived from two standard laboratory measurements that are universally available in Singapore 1:

  • Fasting plasma glucose (measured in mmol/L)
  • Fasting insulin (measured in mU/ml)

The calculation formula is: (Fasting glucose × Fasting insulin) / 22.5 1

Clinical Utility and Recommendations

HOMA-IR provides a surrogate estimate of insulin resistance in persons without diabetes and can be recommended provided proper reference values have been established 1. The EASL-EASD-EASO guidelines give this an A1 level recommendation 1.

When to Use HOMA-IR:

  • Assessment of insulin resistance in non-diabetic individuals - HOMA-IR is most valid when insulin secretion can adapt to insulin resistance 1
  • Evaluation of metabolic dysfunction-associated steatotic liver disease (MASLD) - May clarify metabolic dysfunction in adults without established type 2 diabetes 1
  • Polycystic ovary syndrome (PCOS) assessment - Used as a metabolic outcome measure in clinical trials and practice 1
  • Diagnostic uncertainty cases - Can confirm altered insulin sensitivity in cases like ultrasound-defined steatosis with normal body weight 1

Important Limitations:

  • Questionable validity in overt diabetes - The validity depends on the pancreatic beta-cell's ability to adapt to insulin resistance 1
  • Assay variability - Insulin measurement assays vary widely between laboratories 1
  • No standardized threshold - There is no universal agreement on cut-off values defining insulin resistance using HOMA-IR 1, 2
  • Limited diagnostic use for NAFLD - HOMA-IR has limited utility for NAFLD diagnosis in patients with metabolic risk factors (B2 recommendation) 1

Practical Implementation in Singapore

Since HOMA-IR only requires standard laboratory tests (fasting glucose and insulin), any laboratory in Singapore capable of performing these routine assays can provide the necessary data for calculation 3, 4. The calculation itself can be performed manually, through laboratory information systems, or using online calculators 4.

Alternative Approaches:

HbA1c-based estimation - Recent research shows that HOMA-IR can be estimated using HbA1c-derived estimated average glucose (eAG) instead of fasting glucose, which may be more practical for home sampling 3. This correlation is very strong (r² = 0.9972) 3.

Key Clinical Caveats:

  • Ensure proper fasting - Patients must be truly fasting for accurate results 4
  • Establish local reference values - Cut-off values differ by race, age, gender, and disease state 2
  • Use for monitoring - During follow-up, HOMA-IR may help identify patients at risk of NASH or fibrosis progression, and improvement during weight loss may indicate beneficial metabolic changes (C2 recommendation) 1
  • Single sample advantage - HOMA-IR requires only a single plasma sample, making it more practical than dynamic testing methods like the euglycemic hyperinsulinemic clamp 1, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.